首页 | 本学科首页   官方微博 | 高级检索  
     

三维适形放疗联合XELOX方案同期化疗复发直肠癌疗效分析
引用本文:任涛,谭榜宪,柳弥,陈晓品. 三维适形放疗联合XELOX方案同期化疗复发直肠癌疗效分析[J]. 重庆医学, 2010, 39(17). DOI: 10.3969/j.issn.1671-8348.2010.17.041
作者姓名:任涛  谭榜宪  柳弥  陈晓品
作者单位:川北医学院附属医院肿瘤科,四川南充,637000;重庆医科大学附属第一医院肿瘤科,400016
摘    要:目的探讨三维适形放疗联合希罗达(通用名:卡培他滨)加奥沙利铂(XELOX)方案同期化疗术后复发直肠癌的临床疗效。方法回顾性分析2004年1月至2008年1月采用三维适形放疗联合XELOX方案同期化疗的51例术后复发直肠癌患者的临床资料,并分析其疗效和影响预后的因素。结果全组1、2、3年总生存率分别为86.3%、62.7%、25.5%,中位生存时间28.7个月。多因素分析表明,肿瘤复发时间(P<0.000 1)、原发肿瘤T分期(P=0.0018)是术后复发直肠癌患者的独立预后因素。不良反应以手足综合征和消化道反应发生率较高,但多为Ⅰ~Ⅱ度。结论三维适形放疗联合XELOX方案同期化疗术后复发直肠癌疗效明显。肿瘤复发时间、原发肿瘤T分期是影响术后复发直肠癌患者预后的独立因素。

关 键 词:直肠癌  化学疗法  放射治疗

Efficacy of three-dimensional conformal radiotherapy plus XELOX regime concurrent chemotherapy for patients with recurrent rectal cancer
REN Tao,TAN Bang-xian,LIU Mi,et al.. Efficacy of three-dimensional conformal radiotherapy plus XELOX regime concurrent chemotherapy for patients with recurrent rectal cancer[J]. Chongqing Medical Journal, 2010, 39(17). DOI: 10.3969/j.issn.1671-8348.2010.17.041
Authors:REN Tao  TAN Bang-xian  LIU Mi  et al.
Affiliation:REN Tao1,TAN Bang-xian1,LIU Mi1,et al.(1.Department of Oncology,Affiliated Hospital,North Sichuan Medical College,Nanchong 637000,China,2.Department of Oncology,First Affiliated Hospital,Chongqing Medical University,Chongqing 400016,China)
Abstract:Objective To evaluate the efficiency of three-dimensional conformal radiotherapy(3DCRT) combined with XELOX regimen(xeloda plus oxaliplatin) concurrent chemotherapy for postoperative recurrent rectal cancer(RCC).Methods From January 2004 to January 2008,fifty-one patients with RCC were treated with three-dimensional conformal radiotherapy combined with XELOX regimen concurrent chemotherapy,their clinical data were analyzed retrospectively.Results The overall 1,2,3-year survival rates were 86.3%,62.7% and 25...
Keywords:rectal cancer  chemotherapy  radiotherapy  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号